Radionuclide Studies in the Determination of Brain Death: Criteria, Concepts, and Controversies

Lionel S. Zuckier, Johanna Kolano

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

Forty years after the publication of a landmark paper by the Ad Hoc Committee of the Harvard Medical School, the general concept of brain death has achieved widespread acceptance. In the United States, irreversible dysfunction of the brain and brainstem are required for the diagnosis of brain death. Although primarily based on clinical evaluation, confirmatory examinations, including radionuclide blood flow studies, play an important role in augmenting the physical examination in special situations when some of its specific components cannot be performed or reliably evaluated. The 2 main radionuclidic techniques used in evaluation of brain death are radionuclide angiography with nonlipophilic radiopharmaceuticals and parenchymal imaging with lipophilic agents. Specific technical guidelines for determination of brain death have been promulgated by professional medical societies. In the vast majority of cases, blood flow examinations are useful in confirming brain death. Nonetheless, on occasion patients clinically diagnosed with brain death will exhibit persistent intracranial blood flow or electrical activity. Existence of these contradictory cases reveals underlying inconsistencies in the definitions of brain death. We hypothesize that the existence of these apparent contradictions is related to differences in sensitivity of the physical examination and the confirmatory examinations, differences in localization of the physical examination and confirmatory tests, and differences between blood flow and cerebral function as markers of brain death.

Original languageEnglish (US)
Pages (from-to)262-273
Number of pages12
JournalSeminars in nuclear medicine
Volume38
Issue number4
DOIs
StatePublished - Jul 1 2008
Externally publishedYes

Fingerprint

Brain Death
Radioisotopes
Physical Examination
Cerebrovascular Circulation
Radionuclide Angiography
Radiopharmaceuticals
Medical Societies
Medical Schools
Brain Stem
Publications
Guidelines
Brain

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Radionuclide Studies in the Determination of Brain Death : Criteria, Concepts, and Controversies. / Zuckier, Lionel S.; Kolano, Johanna.

In: Seminars in nuclear medicine, Vol. 38, No. 4, 01.07.2008, p. 262-273.

Research output: Contribution to journalReview article

@article{edb32d6a1f7e405b8704623a1ed12110,
title = "Radionuclide Studies in the Determination of Brain Death: Criteria, Concepts, and Controversies",
abstract = "Forty years after the publication of a landmark paper by the Ad Hoc Committee of the Harvard Medical School, the general concept of brain death has achieved widespread acceptance. In the United States, irreversible dysfunction of the brain and brainstem are required for the diagnosis of brain death. Although primarily based on clinical evaluation, confirmatory examinations, including radionuclide blood flow studies, play an important role in augmenting the physical examination in special situations when some of its specific components cannot be performed or reliably evaluated. The 2 main radionuclidic techniques used in evaluation of brain death are radionuclide angiography with nonlipophilic radiopharmaceuticals and parenchymal imaging with lipophilic agents. Specific technical guidelines for determination of brain death have been promulgated by professional medical societies. In the vast majority of cases, blood flow examinations are useful in confirming brain death. Nonetheless, on occasion patients clinically diagnosed with brain death will exhibit persistent intracranial blood flow or electrical activity. Existence of these contradictory cases reveals underlying inconsistencies in the definitions of brain death. We hypothesize that the existence of these apparent contradictions is related to differences in sensitivity of the physical examination and the confirmatory examinations, differences in localization of the physical examination and confirmatory tests, and differences between blood flow and cerebral function as markers of brain death.",
author = "Zuckier, {Lionel S.} and Johanna Kolano",
year = "2008",
month = "7",
day = "1",
doi = "10.1053/j.semnuclmed.2008.03.003",
language = "English (US)",
volume = "38",
pages = "262--273",
journal = "Seminars in Nuclear Medicine",
issn = "0001-2998",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Radionuclide Studies in the Determination of Brain Death

T2 - Criteria, Concepts, and Controversies

AU - Zuckier, Lionel S.

AU - Kolano, Johanna

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Forty years after the publication of a landmark paper by the Ad Hoc Committee of the Harvard Medical School, the general concept of brain death has achieved widespread acceptance. In the United States, irreversible dysfunction of the brain and brainstem are required for the diagnosis of brain death. Although primarily based on clinical evaluation, confirmatory examinations, including radionuclide blood flow studies, play an important role in augmenting the physical examination in special situations when some of its specific components cannot be performed or reliably evaluated. The 2 main radionuclidic techniques used in evaluation of brain death are radionuclide angiography with nonlipophilic radiopharmaceuticals and parenchymal imaging with lipophilic agents. Specific technical guidelines for determination of brain death have been promulgated by professional medical societies. In the vast majority of cases, blood flow examinations are useful in confirming brain death. Nonetheless, on occasion patients clinically diagnosed with brain death will exhibit persistent intracranial blood flow or electrical activity. Existence of these contradictory cases reveals underlying inconsistencies in the definitions of brain death. We hypothesize that the existence of these apparent contradictions is related to differences in sensitivity of the physical examination and the confirmatory examinations, differences in localization of the physical examination and confirmatory tests, and differences between blood flow and cerebral function as markers of brain death.

AB - Forty years after the publication of a landmark paper by the Ad Hoc Committee of the Harvard Medical School, the general concept of brain death has achieved widespread acceptance. In the United States, irreversible dysfunction of the brain and brainstem are required for the diagnosis of brain death. Although primarily based on clinical evaluation, confirmatory examinations, including radionuclide blood flow studies, play an important role in augmenting the physical examination in special situations when some of its specific components cannot be performed or reliably evaluated. The 2 main radionuclidic techniques used in evaluation of brain death are radionuclide angiography with nonlipophilic radiopharmaceuticals and parenchymal imaging with lipophilic agents. Specific technical guidelines for determination of brain death have been promulgated by professional medical societies. In the vast majority of cases, blood flow examinations are useful in confirming brain death. Nonetheless, on occasion patients clinically diagnosed with brain death will exhibit persistent intracranial blood flow or electrical activity. Existence of these contradictory cases reveals underlying inconsistencies in the definitions of brain death. We hypothesize that the existence of these apparent contradictions is related to differences in sensitivity of the physical examination and the confirmatory examinations, differences in localization of the physical examination and confirmatory tests, and differences between blood flow and cerebral function as markers of brain death.

UR - http://www.scopus.com/inward/record.url?scp=44249096552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44249096552&partnerID=8YFLogxK

U2 - 10.1053/j.semnuclmed.2008.03.003

DO - 10.1053/j.semnuclmed.2008.03.003

M3 - Review article

C2 - 18514082

AN - SCOPUS:44249096552

VL - 38

SP - 262

EP - 273

JO - Seminars in Nuclear Medicine

JF - Seminars in Nuclear Medicine

SN - 0001-2998

IS - 4

ER -